Catalyst Pharmaceuticals, Inc.CPRXNASDAQ
Loading
SG&A Expenses Over TimeStrong
Percentile Rank100
3Y CAGR+50.3%
5Y CAGR+34.4%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
+50.3%/yr
vs +37.7%/yr prior
5Y CAGR
+34.4%/yr
Recent acceleration
Acceleration
+12.6pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
4.4x
Strong expansion
Streak
8 yr
Consecutive growthStrong
PeriodValueYoY Change
TTM$193.75M+9.0%
2024$177.74M+32.9%
2023$133.71M+134.2%
2022$57.09M+15.0%
2021$49.63M+12.2%
2020$44.23M+19.9%
2019$36.88M+132.3%
2018$15.88M+117.3%
2017$7.30M-7.7%
2016$7.91M-